MOLECULAR ENERGIES
PLC
("Molecular" or the "Company")
Issue of
Equity
Molecular Energies (AIM: MEN), the
international energy company, announces that, to satisfy payment of
advisory services provided to the Company, it has allotted 160,000
new Ordinary Shares of 1 pence each in the Company ("Ordinary
Shares").
Application will be made for the new
Ordinary Shares to be admitted to trading on AIM and dealings are
expected to commence on 1 February 2024.
The new Ordinary Shares will rank
pari passu with the Company's existing Ordinary Shares. The total
number of Ordinary Shares in issue following Admission will be
12,378,197. The Company does not hold any shares in treasury.
Accordingly, the figure of 12,378,197 may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in the Company under the FCA's Disclosure
Guidance and Transparency Rules.
For more information, please
visit www.molecularenergiesplc.com
or contact:
|
Molecular Energies PLC
Peter Levine, Chairman
Rob Shepherd, Group FD
|
+44 (0)20 7016 7950
info@molecularenergiesplc.com
|
|
Cavendish Capital Markets Limited (Nominated Adviser
& Broker)
Simon Hicks, George Dollemore
|
+44 (0)20 7220 0500
|
|
Tavistock (Financial PR & IR)
Simon Hudson, Nick Elwes, Charles
Baister
|
+44 (0)20 7920 3150
|
Notes to Editors
Molecular Energies PLC is an AIM
listed company at the forefront of energy development and has
interests across the energy spectrum, from an oil and gas project
to the green and alternative energy sector.
The Company currently has an oil
exploration asset in Paraguay. The Company has two separate
subdivisions which are focused on early-stage opportunities in the
green and/or alternative energy sub-sector.
Activities in the green and
alternative energy space are being carried out direct through
Molecular and under the Green House Capital brand and through AIM
listed Atome Energy PLC, a green hydrogen, ammonia, and fertiliser
company operating in Paraguay, Costa Rica and Iceland, in which
Molecular currently has 20.5%.
With a strong strategic and
institutional base of support, no third-party financial debt and a
Chairman whose interests as the largest shareholder are aligned to
those of its shareholders, Molecular gives UK investors access to
an energy growth story combined with world class standards of
corporate governance, environmental and social
responsibility.
-ends-